Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2017 December;59(4) > Panminerva Medica 2017 December;59(4):302-7

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW   

Panminerva Medica 2017 December;59(4):302-7

DOI: 10.23736/S0031-0808.16.03236-5

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis

Hong CHEN 1, Nan HU 2, Peng CHANG 1, Tao KANG 1, Song HAN 1, Yaoliang LU 1 , Maoquan LI 2

1 Department of General Surgery, Taicang Hospital Affiliated to Soochow University, Taicang, Jiangsu, China; 2 Department of Vascular Surgery, Shanghai Tenth People’s Hospital Affiliated to Tongji University, Shanghai, China


PDF


INTRODUCTION: Hepatocellular carcinoma (HCC) is the fifth-most common cancer. Recent studies have demonstrated that there was a relationship between modified Glasgow prognostic score (mGPS) and survival of HCC. However, the results were inconsistent.
EVIDENCE ACQUISITION: The following databases were searched for relevant articles published until June 2016: PubMed; EMBASE; Web of Science and the China National Knowledge Infrastructure. The strength of association between mGPS and OS of HCC was estimated by pooled HRs with corresponding 95% CIs.
EVIDENCE SYNTHESIS: Seven studies with 2047 HCC patients were included in this meta-analysis. The mGPS was an independent marker of poor prognosis in patients with HCC (HR=2.21; 95% CI: 1.73-2.82; I2=51%). In the subgroup analysis of study design, both prospective studies (HR=1.68; 95% CI: 1.35-2.11; I2=0%) and retrospective studies (HR=2.64; 95% CI: 1.92-3.62; I2=39%) with higher mGPS had shorter OS. The patients with resectable HCC and high mGPS also showed shorter OS (HR=2.33; 95% CI: 1.65-3.29; I2=63%). In the subgroup analysis by sample size, both large sample size studies (HR=2.56; 95% CI: 1.50-4.38; I2=72%) and small sample size studies (HR=2.00; 95% CI: 1.62-2.48; I2=0%) showed the same results.
CONCLUSIONS: In conclusion, this meta-analysis suggested that mGPS might be an independent prognostic factor for HCC.


KEY WORDS: Carcinoma, hepatocellular - Meta-analysis as topic - Survival

inizio pagina